Treatment of osteochondral lesions of the talus with particulated juvenile cartilage

J. Chris Coetzee, Eric Giza, Lew C. Schon, Gregory C. Berlet, Steven Neufeld, Rebecca M. Stone, Erin L. Wilson

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Background: Numerous modalities are used today to treat symptomatic osteochondral lesions in the ankle. However, there are ongoing challenges with the treatment of certain lesions, and concerns exist regarding long-term effectiveness. Methods: The purpose of the study was to collect clinical outcomes of pain and function in retrospectively and prospectively enrolled patients treated with particulated juvenile cartilage for symptomatic osteochondral lesions in the ankle. This study collected outcomes and incidence of reoperations in standard clinic patients. The analysis presented here includes final follow-up to date for 12 males and 11 females representing 24 ankles. Subjects had an average age at surgery of 35.0 years and an average body mass index of 28 ± 5.8. Fourteen ankles had failed at least 1 prior bone marrow stimulation procedure. The average lesion size was 125 ± 75 mm2, and the average depth was 7 ± 5 mm. In conjunction with the treatment, 9 (38%) ankles had 1 concomitant procedure and 9 (38%) had more than 1 concomitant procedure. Clinical evaluations were performed with an average follow-up of 16.2 months. Results: Average outcome scores at final follow-up were American Orthopaedic Foot & Ankle Society Ankle-Hindfoot Scale 85 ± 18 with 18 (78%) ankles demonstrating good to excellent scores, Short-Form 12 Health Survey (SF12) physical composite score 46 ± 10, SF12 mental health composite score 55 ± 7.1, Foot and Ankle Ability Measure (FAAM) activities of daily living 82 ± 14, FAAM Sports 63 ± 27, and 100-mm visual analog scale for pain 24 ± 25. Outcomes data divided by lesion size demonstrated 92% (12/13) good to excellent results in lesions 10 mm or larger and those smaller than 15 mm. To date, 1 partial graft delamination has been reported at 16 months. Conclusions: Preliminary data from a challenging clinical population with large, symptomatic osteochondral lesions in the ankle suggest that treatment with particulated juvenile cartilage could improve function and decrease pain. Longer followup and additional subjects are needed to evaluate improvement level and ideal patient indications. Level of Evidence: Level IV, case series.

Original languageEnglish (US)
Pages (from-to)1205-1211
Number of pages7
JournalFoot and Ankle International
Volume34
Issue number9
DOIs
StatePublished - Sep 2013

Fingerprint

Talus
Ankle
Cartilage
Therapeutics
Foot
Aptitude
Pain
Pain Measurement
Activities of Daily Living
Health Surveys
Reoperation
Sports
Orthopedics
Mental Health
Body Mass Index
Cohort Studies
Bone Marrow
Outcome Assessment (Health Care)

Keywords

  • articular cartilage repair
  • cartilage allograft
  • clinical outcomes
  • lesion size
  • osteochondral defects
  • talus

ASJC Scopus subject areas

  • Surgery
  • Orthopedics and Sports Medicine

Cite this

Coetzee, J. C., Giza, E., Schon, L. C., Berlet, G. C., Neufeld, S., Stone, R. M., & Wilson, E. L. (2013). Treatment of osteochondral lesions of the talus with particulated juvenile cartilage. Foot and Ankle International, 34(9), 1205-1211. https://doi.org/10.1177/1071100713485739

Treatment of osteochondral lesions of the talus with particulated juvenile cartilage. / Coetzee, J. Chris; Giza, Eric; Schon, Lew C.; Berlet, Gregory C.; Neufeld, Steven; Stone, Rebecca M.; Wilson, Erin L.

In: Foot and Ankle International, Vol. 34, No. 9, 09.2013, p. 1205-1211.

Research output: Contribution to journalArticle

Coetzee, JC, Giza, E, Schon, LC, Berlet, GC, Neufeld, S, Stone, RM & Wilson, EL 2013, 'Treatment of osteochondral lesions of the talus with particulated juvenile cartilage', Foot and Ankle International, vol. 34, no. 9, pp. 1205-1211. https://doi.org/10.1177/1071100713485739
Coetzee, J. Chris ; Giza, Eric ; Schon, Lew C. ; Berlet, Gregory C. ; Neufeld, Steven ; Stone, Rebecca M. ; Wilson, Erin L. / Treatment of osteochondral lesions of the talus with particulated juvenile cartilage. In: Foot and Ankle International. 2013 ; Vol. 34, No. 9. pp. 1205-1211.
@article{07e467f3313847cea15fb02b13b56d4a,
title = "Treatment of osteochondral lesions of the talus with particulated juvenile cartilage",
abstract = "Background: Numerous modalities are used today to treat symptomatic osteochondral lesions in the ankle. However, there are ongoing challenges with the treatment of certain lesions, and concerns exist regarding long-term effectiveness. Methods: The purpose of the study was to collect clinical outcomes of pain and function in retrospectively and prospectively enrolled patients treated with particulated juvenile cartilage for symptomatic osteochondral lesions in the ankle. This study collected outcomes and incidence of reoperations in standard clinic patients. The analysis presented here includes final follow-up to date for 12 males and 11 females representing 24 ankles. Subjects had an average age at surgery of 35.0 years and an average body mass index of 28 ± 5.8. Fourteen ankles had failed at least 1 prior bone marrow stimulation procedure. The average lesion size was 125 ± 75 mm2, and the average depth was 7 ± 5 mm. In conjunction with the treatment, 9 (38{\%}) ankles had 1 concomitant procedure and 9 (38{\%}) had more than 1 concomitant procedure. Clinical evaluations were performed with an average follow-up of 16.2 months. Results: Average outcome scores at final follow-up were American Orthopaedic Foot & Ankle Society Ankle-Hindfoot Scale 85 ± 18 with 18 (78{\%}) ankles demonstrating good to excellent scores, Short-Form 12 Health Survey (SF12) physical composite score 46 ± 10, SF12 mental health composite score 55 ± 7.1, Foot and Ankle Ability Measure (FAAM) activities of daily living 82 ± 14, FAAM Sports 63 ± 27, and 100-mm visual analog scale for pain 24 ± 25. Outcomes data divided by lesion size demonstrated 92{\%} (12/13) good to excellent results in lesions 10 mm or larger and those smaller than 15 mm. To date, 1 partial graft delamination has been reported at 16 months. Conclusions: Preliminary data from a challenging clinical population with large, symptomatic osteochondral lesions in the ankle suggest that treatment with particulated juvenile cartilage could improve function and decrease pain. Longer followup and additional subjects are needed to evaluate improvement level and ideal patient indications. Level of Evidence: Level IV, case series.",
keywords = "articular cartilage repair, cartilage allograft, clinical outcomes, lesion size, osteochondral defects, talus",
author = "Coetzee, {J. Chris} and Eric Giza and Schon, {Lew C.} and Berlet, {Gregory C.} and Steven Neufeld and Stone, {Rebecca M.} and Wilson, {Erin L.}",
year = "2013",
month = "9",
doi = "10.1177/1071100713485739",
language = "English (US)",
volume = "34",
pages = "1205--1211",
journal = "Foot and Ankle International",
issn = "1071-1007",
publisher = "AOFAS - American Orthopaedic Foot and Ankle Society",
number = "9",

}

TY - JOUR

T1 - Treatment of osteochondral lesions of the talus with particulated juvenile cartilage

AU - Coetzee, J. Chris

AU - Giza, Eric

AU - Schon, Lew C.

AU - Berlet, Gregory C.

AU - Neufeld, Steven

AU - Stone, Rebecca M.

AU - Wilson, Erin L.

PY - 2013/9

Y1 - 2013/9

N2 - Background: Numerous modalities are used today to treat symptomatic osteochondral lesions in the ankle. However, there are ongoing challenges with the treatment of certain lesions, and concerns exist regarding long-term effectiveness. Methods: The purpose of the study was to collect clinical outcomes of pain and function in retrospectively and prospectively enrolled patients treated with particulated juvenile cartilage for symptomatic osteochondral lesions in the ankle. This study collected outcomes and incidence of reoperations in standard clinic patients. The analysis presented here includes final follow-up to date for 12 males and 11 females representing 24 ankles. Subjects had an average age at surgery of 35.0 years and an average body mass index of 28 ± 5.8. Fourteen ankles had failed at least 1 prior bone marrow stimulation procedure. The average lesion size was 125 ± 75 mm2, and the average depth was 7 ± 5 mm. In conjunction with the treatment, 9 (38%) ankles had 1 concomitant procedure and 9 (38%) had more than 1 concomitant procedure. Clinical evaluations were performed with an average follow-up of 16.2 months. Results: Average outcome scores at final follow-up were American Orthopaedic Foot & Ankle Society Ankle-Hindfoot Scale 85 ± 18 with 18 (78%) ankles demonstrating good to excellent scores, Short-Form 12 Health Survey (SF12) physical composite score 46 ± 10, SF12 mental health composite score 55 ± 7.1, Foot and Ankle Ability Measure (FAAM) activities of daily living 82 ± 14, FAAM Sports 63 ± 27, and 100-mm visual analog scale for pain 24 ± 25. Outcomes data divided by lesion size demonstrated 92% (12/13) good to excellent results in lesions 10 mm or larger and those smaller than 15 mm. To date, 1 partial graft delamination has been reported at 16 months. Conclusions: Preliminary data from a challenging clinical population with large, symptomatic osteochondral lesions in the ankle suggest that treatment with particulated juvenile cartilage could improve function and decrease pain. Longer followup and additional subjects are needed to evaluate improvement level and ideal patient indications. Level of Evidence: Level IV, case series.

AB - Background: Numerous modalities are used today to treat symptomatic osteochondral lesions in the ankle. However, there are ongoing challenges with the treatment of certain lesions, and concerns exist regarding long-term effectiveness. Methods: The purpose of the study was to collect clinical outcomes of pain and function in retrospectively and prospectively enrolled patients treated with particulated juvenile cartilage for symptomatic osteochondral lesions in the ankle. This study collected outcomes and incidence of reoperations in standard clinic patients. The analysis presented here includes final follow-up to date for 12 males and 11 females representing 24 ankles. Subjects had an average age at surgery of 35.0 years and an average body mass index of 28 ± 5.8. Fourteen ankles had failed at least 1 prior bone marrow stimulation procedure. The average lesion size was 125 ± 75 mm2, and the average depth was 7 ± 5 mm. In conjunction with the treatment, 9 (38%) ankles had 1 concomitant procedure and 9 (38%) had more than 1 concomitant procedure. Clinical evaluations were performed with an average follow-up of 16.2 months. Results: Average outcome scores at final follow-up were American Orthopaedic Foot & Ankle Society Ankle-Hindfoot Scale 85 ± 18 with 18 (78%) ankles demonstrating good to excellent scores, Short-Form 12 Health Survey (SF12) physical composite score 46 ± 10, SF12 mental health composite score 55 ± 7.1, Foot and Ankle Ability Measure (FAAM) activities of daily living 82 ± 14, FAAM Sports 63 ± 27, and 100-mm visual analog scale for pain 24 ± 25. Outcomes data divided by lesion size demonstrated 92% (12/13) good to excellent results in lesions 10 mm or larger and those smaller than 15 mm. To date, 1 partial graft delamination has been reported at 16 months. Conclusions: Preliminary data from a challenging clinical population with large, symptomatic osteochondral lesions in the ankle suggest that treatment with particulated juvenile cartilage could improve function and decrease pain. Longer followup and additional subjects are needed to evaluate improvement level and ideal patient indications. Level of Evidence: Level IV, case series.

KW - articular cartilage repair

KW - cartilage allograft

KW - clinical outcomes

KW - lesion size

KW - osteochondral defects

KW - talus

UR - http://www.scopus.com/inward/record.url?scp=84884182778&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884182778&partnerID=8YFLogxK

U2 - 10.1177/1071100713485739

DO - 10.1177/1071100713485739

M3 - Article

C2 - 23576118

AN - SCOPUS:84884182778

VL - 34

SP - 1205

EP - 1211

JO - Foot and Ankle International

JF - Foot and Ankle International

SN - 1071-1007

IS - 9

ER -